What is the treatment for pyelonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pyelonephritis

For outpatient treatment of acute pyelonephritis, oral ciprofloxacin 500 mg twice daily for 7 days is the first-line therapy when local fluoroquinolone resistance is below 10%, with levofloxacin 750 mg once daily for 5 days as an equally effective alternative. 1, 2

Initial Assessment

  • Always obtain urine culture and susceptibility testing before initiating antibiotics to guide definitive therapy and adjust treatment based on culture results. 1, 2
  • Tailor initial empirical therapy based on local resistance patterns, particularly fluoroquinolone resistance rates in your community. 1, 2

Outpatient Treatment Algorithm

When Fluoroquinolone Resistance is <10%:

First-line options:

  • Ciprofloxacin 500 mg orally twice daily for 7 days (with or without an initial 400 mg IV dose). 1, 2
  • Levofloxacin 750 mg orally once daily for 5 days as an equally effective alternative. 1, 2, 3
  • Ciprofloxacin 1000 mg extended-release orally once daily for 7 days is also appropriate. 1, 2

The 7-day ciprofloxacin regimen is supported by high-quality evidence showing 97% short-term clinical cure rates and 93% long-term efficacy, with no difference compared to 14-day treatment. 4

When Fluoroquinolone Resistance is >10%:

  • Administer an initial one-time IV dose of ceftriaxone 1 g OR a consolidated 24-hour dose of an aminoglycoside (e.g., gentamicin 5-7 mg/kg), followed by oral fluoroquinolone therapy. 1, 2

Alternative Therapy (when fluoroquinolones cannot be used):

  • Trimethoprim-sulfamethoxazole 160/800 mg (double-strength tablet) twice daily for 14 days ONLY if the uropathogen is known to be susceptible. 1, 2
  • If using TMP-SMX empirically when susceptibility is unknown, give an initial IV dose of ceftriaxone 1 g or aminoglycoside first. 1

Inpatient Treatment

Indications for hospitalization include: complicated infections, sepsis, persistent vomiting, failed outpatient treatment, or extremes of age. 5

IV antibiotic options:

  • Fluoroquinolone (ciprofloxacin or levofloxacin) 2, 5
  • Aminoglycoside with or without ampicillin 2, 5
  • Extended-spectrum cephalosporin (e.g., ceftriaxone) 2, 5
  • Extended-spectrum penicillin with or without aminoglycoside 2, 5
  • Carbapenem 2

Choice should be based on local resistance patterns and adjusted according to culture results. 2

Treatment Duration by Antibiotic Class

  • Fluoroquinolones: 5-7 days depending on the specific agent (levofloxacin 5 days, ciprofloxacin 7 days). 1, 2, 4
  • Trimethoprim-sulfamethoxazole: 14 days (traditional recommendation). 1, 2
  • β-lactams: 10-14 days (longer duration required due to inferior efficacy). 2

Evidence Considerations

The superiority of fluoroquinolones is well-established, with ciprofloxacin demonstrating significantly higher microbiological cure rates (99% vs 89%) and clinical cure rates (96% vs 83%) compared to trimethoprim-sulfamethoxazole. 1, 6 The 5-day levofloxacin 750 mg regimen was proven non-inferior to 10-day ciprofloxacin in a large randomized trial of 1109 patients. 3

Common Pitfalls to Avoid

  • Never start antibiotics without obtaining urine cultures first - this is the most critical error that limits your ability to adjust therapy. 2
  • Do not use fluoroquinolones empirically in areas with >10% resistance without adding an initial parenteral dose - this significantly reduces treatment failure. 2, 6
  • Avoid oral β-lactams as monotherapy without an initial parenteral dose - they have inferior efficacy compared to fluoroquinolones. 1, 2, 6
  • Do not use amoxicillin or ampicillin empirically - resistance rates are extremely high worldwide. 1
  • Never fail to adjust therapy based on culture results - even if the patient is improving clinically. 2
  • Avoid inadequate treatment duration with β-lactam agents - they require 10-14 days, not the shorter courses used for fluoroquinolones. 2

Follow-up

  • Repeat urine culture 1-2 weeks after completion of antibiotic therapy to confirm eradication. 5
  • If treatment fails, repeat blood and urine cultures and consider imaging studies to evaluate for resistant organisms, anatomic abnormalities, or immunosuppression. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Pyelonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Pyelonephritis with Fluoroquinolones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.